# Clinical Study to Evaluate Clinical Impact of PGx-Guided Treatment for Patients Undergoing Elective Spinal Surgical Procedures

> **NCT02599870** · NA · TERMINATED · sponsor: **AltheaDx** · enrollment: 56 (actual)

## Conditions studied

- Acute Pain
- Surgery

## Interventions

- **GENETIC:** NeuroIDgenetix Test Panel

## Key facts

- **NCT ID:** NCT02599870
- **Lead sponsor:** AltheaDx
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-09
- **Primary completion:** 2016-02
- **Final completion:** 2016-02
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2018-07-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02599870

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02599870, "Clinical Study to Evaluate Clinical Impact of PGx-Guided Treatment for Patients Undergoing Elective Spinal Surgical Procedures". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02599870. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*